Effective volume study of ultrasound-guided 0.5% ropivacaine erector spinal block on postoperative analgesia in patients undergoing video-assisted thoracoscopic lobectomy

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045407

Enrollment

Unknown

Registered

2021-04-14

Start date

2021-04-19

Completion date

Unknown

Last updated

2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lobectomy

Interventions

Erector spinal plane block group:Erector spinal block was performed with 0.5% ropivacaine

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age:18 - 65 years old; 2.Weight:40 - 85 kg; 3.ASA I or II; 4.Patients undergoing video-assisted thoracoscopic lobectomy.

Exclusion criteria

Exclusion criteria: 1. Infection or skin disease at the puncture site: 2. BMI > 35 kg/m^2; 3. Abnormal heart, lung, liver, kidney, nervous system and coagulation function; 4. Have a history of allergy to local anesthetics and intraoperative medication; 5. Preoperative use of drugs affecting neurological function; 6. Previous use of opioids or antipsychotic medications.

Design outcomes

Primary

Measure	Time frame
Nerve block segment;Visual analogue scoring;Patient controlled intravenousanalgesia;	—

Countries

China

Contacts

Public ContactHe Zhongxian

Guangzhou Panyu Central Hospital

61305566@qq.com+86 13751845410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026